secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0001493152-23-024613
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Health amends merger with Superlatus; adds share rights for existing holders
--------------------------------------------------------------------------------

- Superlatus shareholders get 30,821,941 shares at $7.30: 136,441 common (19.99% post-merger) and 306,855 Series B convertible preferred (100:1).
- TRxADE to issue non-transferable MEDS Rights: 7 rights per share held, each for one free common share, record date one day before closing.
- Ancillary document deadline extended to 10 days; certain MEDS equity holders will sign lock-up agreements.
- Rights holders must sign Registration Rights Agreement; shares locked for one year post-closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223024613/0001493152-23-024613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223024613/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer